Creative Planning Reduces Stock Holdings in Ligand Pharmaceuticals Inc. (NASDAQ:LGND)

  • Summary:


    Creative Planning lessened its position in shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) by 4.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,706 shares of the biotechnology company’s stock after selling 435 shares during the quarter. Creative Planning owned about 0.05% of Ligand Pharmaceuticals worth $966,000 as of its most recent SEC filing.

    A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in LGND. Janus Henderson Group PLC grew its holdings in Ligand Pharmaceuticals by 11.4% during the 2nd quarter. Janus Henderson Group PLC now owns 1,542,670 shares of the biotechnology company’s stock valued at $176,096,000 aft ...



    Read Full News:

Log in to reply